| 标题 |
Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet HIV 作者:Catherine Orrell; Debbie P Hagins; Elena Belonosova; Norma Porteiro; Sharon Walmsley; et al 出版日期:2017 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)